Search
Menu
Home
HTB
2018
July
11
HTB
11 July 2018
Contents
Editorial
11 July 2018: vol 19 no 12: DTG and preconception – special report
Special reports
HIV pipeline 2018: full version
Dolutegravir preconception signal: time is up for shoddy surveillance
Conference reports
AIDS 2018: Programme online and late-breaker highlights announced three weeks before the conference
Antiretrovirals
Bictegravir/FTC/TAF (Biktarvy) approved in Europe
Women's health
Dolutegravir: need to consider all pros and cons before switching in pregnancy
Pregnancy
Why U=U does not apply to breastfeeding
PDFs
11 July 2018: vol 19 no 12
HTB RSS
Early access
Detailed results from Palm007 study: no clinical impact of tecovirimat against mpox clade 1
6 January 2025
Tecovirimat news continues: Japan approval includes mpox indication
2 January 2025
Looking back through 2024 and forward to 2025…
1 January 2025
Transient impact of lenacapavir against MDR HIV-2 without other active ART
1 January 2025
All early access reports
Current issues
January 2025
December 2024
November 2024
Back issues
Special report
Detailed results from Palm007 study: no clinical impact of tecovirimat against mpox clade 1
6 January 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate